MARK2 and Miyoshi myopathy: Notably, activating alterations of the BRAF serine/threonine kinase gene have also been recently described in whole-genome and exome sequencing (WGS/WES) studies of MM further extending the evidence of a widespread dysregulation of MAPK signalling in the disease [4-6, 24].